Showing all posts written by Shuchen Gong

Shuchen Gong
Shuchen Gong
Shuchen Gong is an associate in our San Francisco Office. Her practice focuses on the preparation and prosecution of patent applications. Shuchen received her law degree from Cornell Law School and her B.S. in Chemistry and B.A. in Economics from the University of California, Berkeley.

Shuchen joined the firm in 2017.

Abbott Obtains FDA Approval for HeartMate 3 Device

Abbott announced on October 19, 2018 that its HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S. Food and Drug Administration (FDA) approval as a destination therapy for people living with advanced heart failure. Physicians

Cyberattacks and the Value of Medical Data

On July 20, 2018, SingHealth, a Singapore healthcare institution consisting of four public hospitals, five national specialty centers and a network of nine polyclinics, reported that it had been the target of a cyberattack resulting in

Microbot Medical to Acquire CardioSert’s Technology

Microbot Medical Inc. announced that it entered into an agreement with CardioSert Ltd. to acquire CardioSert’s patented guidewire technology, including R&D information, technical know-how, and intellectual property.

Microbot